
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
 "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" lang="en">

<head>
<meta name="google-site-verification" content="tpATPqNEN3HXiSbtqevBE9NdgbuCiN9Vmr6EP94lx6w" />
<meta name="keywords" content="OIG Online Portfolio: Drug Pricing and Reimbursement" />
<meta name="description" content="OIG Online Portfolio: Drug Pricing and Reimbursement" />
<title>OIG Online Portfolio: Drug Pricing and Reimbursement  | Reports & Publications | Office of Inspector General | U.S. Department of Health and Human Services</title>
<!--#include virtual="/layout/head.asp" -->




<link rel="stylesheet" type="text/css" href="./tabs.css" />
<script type="text/javascript" src="./stepcarousel.js">



/***********************************************
* Step Carousel Viewer script- (c) Dynamic Drive DHTML code library (www.dynamicdrive.com)
* Visit http://www.dynamicDrive.com for hundreds of DHTML scripts
* Please keep this notice intact
***********************************************/

</script>

<style type="text/css">

.stepcarousel{
position: relative; /*leave this value alone*/
overflow: scroll; /*leave this value alone*/
width: 585px; /*Width of Carousel Viewer itself*/
height: 240px; /*Height should enough to fit largest content's height*/
-webkit-box-sizing: border-box; /* set box model so container width and height value includes any padding/border defined */
-moz-box-sizing: border-box;
box-sizing: border-box;
}

.stepcarousel .belt{
position: absolute; /*leave this value alone*/
left: 0;
top: 0;
}

.stepcarousel .panel{
float: left; /*leave this value alone*/
overflow: hidden; /*clip content that go outside dimensions of holding panel DIV*/
margin: 0; /*margin around each panel*/
width: 150px; /*Width of each panel holding each content. If removed, widths should be individually defined on each content DIV then. */
}

span.paginatecircle{ /* CSS for paginate circle spans. Required */
background: white;
border: 2px solid black;
border-radius: 10px;
width: 6px;
height: 6px;
cursor: pointer;
display: inline-block;
margin-right: 4px;
}

span.paginatecircle:hover{
background: gray;
}

span.paginatecircle.selected{
background: black;
}

/* .caption {position:absolute; z-index:10; top:140px; left:0; width:125px;} */
.caption {width:125px; padding-left:4px; line-height:1.1}

.no-bg-exit {background-image:none !important;}

</style>



<script type="text/javascript">

stepcarousel.setup({
	galleryid: 'mygallery', //id of carousel DIV
	beltclass: 'belt', //class of inner "belt" DIV containing all the panel DIVs
	panelclass: 'panel', //class of panel DIVs each holding content
	autostep: {enable:true, moveby:1, pause:2000},
	panelbehavior: {speed:500, wraparound:true, wrapbehavior:'slide', persist:true},
	defaultbuttons: {enable: true, moveby: 1, leftnav: ['/fraud/child-support-enforcement/images/prev.gif', -5, 80], rightnav: ['/fraud/child-support-enforcement/images/next.gif', -12, 80]},
	statusvars: ['statusA', 'statusB', 'statusC'], //register 3 variables that contain current panel (start), current panel (last), and total panels
	contenttype: ['inline'] //content setting ['inline'] or ['ajax', 'path_to_external_file']
})


</script>







<!-------------/ head closes and body opens / --->

<!--#include virtual="/layout/head-body-tags.asp" -->

<!------------/ head closes and body opens / --->


<div id="bodyContainer">
	<div id="textReset">
	<!--#include virtual="/layout/header.asp" -->
			<div id="mainBody">
			<div id="leftSideInterior">
				<div id="breadcrumbs">
					<ul>
						<li>
							<a href="/">Home</a>
						</li>
						<li>
							<a href="/reports-and-publications/index.asp">Reports &amp; Publications</a>
						</li>
					
						<li>
						  Portfolio and Other Reports
						</li>
					
					</ul>
				</div>
				<div id="leftContentInterior">



				<h1 id="port">OIG Online Portfolio: Drug Pricing and Reimbursement</h1>

        
        
<p style="margin-bottom:20px;">This online portfolio pulls together the Office of Inspector General's (OIG) body of work since 2010 plus several older relevant items that relate to drug pricing and reimbursement in HHS programs. The portfolio features planned work, completed reports, industry guidance, and enforcement actions. This portfolio does not cover OIG's body of work focused on questionable or fraudulent billing for prescription drugs. This portfolio on drug pricing and reimbursement will be updated periodically.</p>          
          

<div id="tab-top">
<ul>
<li><a href="./index.asp#mainBody">Overview</a></li>
<li><a href="./reports.asp#mainBody">Reports</a></li>
<li id="selected"><a href="./impact.asp#mainBody">Impact</a></li>
<li><a href="./recommendations.asp#mainBody">Recommendations</a></li>
<li><a href="./enforcement.asp#mainBody">Enforcement</a></li>
<li><a href="./guidance.asp#mainBody">Industry Guidance</a></li>
</ul>
</div>



<div id="tab-container">

<h2>Impact</h2>

<div id="tab-interior">

<p>Through audits, investigations, evaluations, and enforcement actions related to drug pricing and reimbursement, OIG carries out its mission of protecting HHS programs and the beneficiaries they serve.  OIG also supports this mission by providing compliance program guidance to the health care industry.  </p>
<p>OIG audit and evaluation reports aim to provide timely, useful, and reliable information and recommendations to decisionmakers and the public.  Our recommendations provide ways to improve the economy, efficiency, and effectiveness of HHS programs.  </p>
<p>OIG's recommendations in the area of drug pricing and reimbursement have informed significant legislative and programmatic changes in drug reimbursement methodologies across HHS programs.  Our work on drug reimbursement policies-work that seeks to ensure that the Federal Government and States are appropriately reimbursing for prescription drugs-has resulted in billions in savings for Medicare and Medicaid.  </p>
<p>Below, we highlight some significant OIG recommendations related to drug pricing and reimbursement that have been implemented by HHS or are being implemented.  For unimplemented recommendations related to drug pricing and reimbursement, please see the <a href="./recommendations.asp#mainBody">Recommendations</a> tab.  For enforcement actions and industry guidance on this topic, please see the <a href="./enforcement.asp#mainBody">Enforcement</a> and <a href="./guidance.asp#mainBody">Industry Guidance</a> tabs.</p>





<!-- <style type="text/css">
.nested-tabs {margin-bottom:20px;} 
.nested-tabs ul {margin:0 !important; padding:0 !important; border-bottom:1px solid #aaa;}
.nested-tabs ul li {display:inline; background-image:none !important; padding:0 !important; margin:0 10px 0 0;}
.nested-tabs ul li a {color: #444444; display:inline-block; width:100px; padding:5px 10px; background:#E6EDF3; border-top:1px solid #aaa; border-right:1px solid #aaa;  border-left:1px solid #aaa; 
-webkit-border-top-left-radius: 5px;
-webkit-border-top-right-radius: 5px;
-moz-border-radius-topleft: 5px;
-moz-border-radius-topright: 5px;
border-top-left-radius: 5px;
border-top-right-radius: 5px;}
.nested-tabs ul li a:hover {background:#B6D0DC; text-decoration:none;}
.nested-tabs ul li a.active {background:#B6D0DC; font-weight:bold}
</style> -->


<!-- <div class="nested-tabs">
<ul>
<li><a class="active" href="./recommendations.asp#mainBody">Implemented</a></li>
<li><a href="./unimplemented.asp#mainBody">Unimplemented</a></li>
</ul>
</div> -->

<h3>Implemented Recommendations</h3>


<table border="0" cellpadding="0" cellspacing="0" class="generic_table" style="margin-left:0;">
<tr>
<th scope="col">Impact</th>
<th scope="col">Report</th>
<th scope="col">Vehicle Of Implementation</th>
<th scope="col">Area of Work</th>
</tr>

<tr>
<td>CMS should seek a legislative change requiring DME infusion drugs to be paid using the ASP methodology.</td>
<td><a href="https://oig.hhs.gov/oei/reports/oei-12-12-00310.asp">Part B Payments for Drugs Infused Through Durable Medical Equipment (OEI-12-12-00310)</a></td>
<td>21st Century Cures Act, Section 5004, signed into law on December 13, 2016.</td>
<td>Reimbursement Policy</td>
</tr>

<tr>
<td>CMS should require States to bring Medicaid reimbursement for brand-name drugs more in line with the actual acquisition cost of brand-name drugs paid by pharmacies in their States.</td>
<td><a href="https://oig.hhs.gov/oas/reports/region6/60000023.pdf">Medicaid Pharmacy - Actual Acquisition Cost of Brand Name Prescription Drug Products (A-06-00-00023)</a></td>
<td>Medicaid Covered Outpatient Drugs Final Rule (42 CFR 447.502), published on February 1, 2016.</td>
<td>Reimbursement Policy</td>
</tr>


<tr>
<td>CMS should finalize implementation of Federal upper limit (FUL) amounts that are based on average manufacturer prices.</td>
<td><a href="https://oig.hhs.gov/oei/reports/oei-03-11-00060.asp">Replacing Average Wholesale Price: Medicaid Drug Payment Policy (OEI-03-11-00060)</a></td>
<td>Medicaid Covered Outpatient Drugs Final Rule (42 CFR 447.514), published on February 1, 2016.</td>
<td>Reimbursement Policy</td>
</tr>

<td>CMS should seek legislative authority to extend the additional rebate provisions for brand-name drugs to generic drugs.</td>
<td><a href="https://oig.hhs.gov/oas/reports/region6/61500030.asp">Average Manufacturer Prices Increased Faster Than Inflation for Many Generic Drugs (A-06-15-00030)</a> (Previous Review:  <a href="https://oig.hhs.gov/oas/reports/region6/60700042.pdf">Review of Generic Price Increases (A-06-07-00042)</a>)</td>
<td>Bipartisan Budget Act of 2015, Section 602, signed into law on November 2, 2015.</td>
<td>Reimbursement Policy</td>
</tr>

<tr>
<td>CMS should lower Medicare reimbursement amounts for drugs with ASPs that meet the 5-percent threshold specified in section 1847A(d)(3) of the Act.</td>
<td><a href="https://oig.hhs.gov/oei/reports/oei-03-08-00450.pdf">Comparisons of ASPs to AMPs:  An Overview of 2007 (OEI-03-08-00450)</a></td>
<td>CMS implemented an AMP-based price substitution policy for certain drugs that exceeded the 5-percent threshold beginning in April 2013.</td>
<td>Pricing Data Integrity</td>
</tr>


<tr>
<td>CMS should develop a national benchmark that accurately estimates acquisition cost and encourage States to use it in determining Medicaid reimbursement for prescription drugs.</td>
<td><a href="https://oig.hhs.gov/oei/reports/oei-03-11-00060.asp">Replacing Average Wholesale Price: Medicaid Drug Payment Policy (OEI-03-11-00060)</a></td>
<td>CMS developed the National Average Drug Acquisition Cost (NADAC) as an alternative pricing benchmark for States in 2013. </td>
<td>Reimbursement Policy</td>
</tr>
<tr>



<tr>
<td>CMS should seek legislative authority to modify the rebate formula calculation to ensure that manufacturers cannot circumvent additional rebates by bringing new versions of existing brand-name drugs to market. </td>
<td><a href="https://oig.hhs.gov/oas/reports/region6/60900033.pdf">Review of Additional Rebates for Brand-Name Drugs with Multiple Versions (A-06-09-00033)</a></td>
<td>Patient Protection and Affordable Care Act, Section 2501(d), as amended by the Health Care and Education Reconciliation Act of 2010, Section 1206(a), signed into law on March 23, 2010. </td>
<td>Reimbursement Policy</td>
</tr>

<tr>
<td>CMS should change its calculation of volume-weighted ASP. OIG suggested that CMS adopt an alternate equation proposed by OIG, which produces a volume-weighted ASP that is both mathematically correct and consistent with the results of the calculation set forth in section 1847A(b)(3) of the Act.</td>
<td><a href="https://oig.hhs.gov/oei/reports/oei-03-05-00310.pdf">Calculation of Volume-Weighted Average Sales Prices for Medicare Part B Drugs (OEI-03-05-00310)</a></td>
<td>Medicare, Medicaid, and SCHIP Extension Act of 2007, Section 112, signed into law on December 29, 2007.</td>
<td>Pricing Data Integrity</td>
</tr>

<tr>
<td>CMS should continue to encourage all States to collect rebates on physician-administered drugs, especially single-source drugs.</td>
<td><a href="https://oig.hhs.gov/oei/reports/oei-03-02-00660.pdf">Medicaid Rebates for Physician-Administered Drugs (OEI-03-02-00660)</a></td>
<td>Deficit Reduction Act of 2005, Section 6002, signed into law on February 8, 2006.</td>
<td>Program Compliance</td>
</tr>





</table>




<!-- 

<div id="mygallery" class="stepcarousel">
<div class="belt">

<ul>



<div class="panel">
<a href="./challenge01.asp"><img src="./images/agent-generic.png" alt="Effectively administering the Medicaid Program" /></a>
<div class="caption"><p>National Health Care Fraud Takedown 2016</p></div>
</div>


<div class="panel">
<a href="/oei/reports/oei-05-16-00031.asp"><img src="./images/data-brief.png" alt="A graphic representing a data brief" /></a>
<div class="caption"><p>Nationwide Analysis of Common Characteristics in OIG Home Health Fraud Cases</p></div>
</div>


<div class="panel">
<a class="clean" href="/compliance/alerts/guidance/HHA_ Alert2016.pdf"><img src="./images/alert.jpg" alt="A graphic representing an alert" /></a>
<div class="caption"><p>Improper Arrangements and Conduct Involving Home Health Agencies and Physicians</p></div>
</div>


<div class="panel">
<a class="fancybox iframe" href="https://www.youtube.com/embed/fjNcUjTyz8c"><img src="./images/eoo-carousel.jpg" alt="Eye on Oversight Video Series" /></a>
<div class="caption"><p>Video: Home Health Fraud</p></div>
</div>


<div class="panel">
<a target="_blank" href="https://www.justice.gov/usao-ndtx/pr/dallas-doctor-and-three-dallas-area-home-health-agency-owners-convicted-running-large"><img src="./images/cop-car.jpg" alt="An image of a police car" /></a>
<div class="caption"><p>News Release: Doctor, Home Health Agency Owners Convicted</p></div>
</div>


<div class="panel">
<a href="/reports-and-publications/archives/workplan/2016/oig-work-plan-2016.pdf#page=16"><img src="./images/wp.jpg" alt="An image of the Work Plan cover" /></a>
<div class="caption"><p>Work Plan: Home Health</p></div>
</div>



<div class="panel">
<a href="/authorities/docs/cpghome.pdf "><img src="./images/guidance.jpg" alt="An image of a guidance document" /></a>
<div class="caption"><p>Compliance Program Guidance for Home Health Industry</p></div>
</div>


<div class="panel">
<a href="./outcomes.asp"><img src="./images/recommendations.jpg" alt="A graphic with the word recommended written on it" /></a>
<div class="caption"><p>Recommendations</p></div>
</div>
 -->






<div class="contentSeparator"></div>


<!-- Closing out Tab Divs -->
</div>
</div>





				</div><!-- leftContentInterior -->
			</div>	<!-- leftSideInterior ends -->
			<div id="rightSide">
				<!--#include file="./port-nav-pop.asp" -->
        
        
<div id="subNav">

<!--#include file="./impact-sidebar.asp" -->
        
<div class="subNavBottom"></div>
</div><!-- subNav ends -->
<div class="clear"></div>



				<div class="clearPadding"></div>
	
			</div><!-- rightSide ends -->
			<div class="clear"></div>
		</div><!-- mainBody ends -->
	</div><!-- textReset ends -->
</div><!-- bodyContainer ends -->
<div id="footerContainer">
	<!--#include virtual="/layout/footer-top.asp" -->
</div><!-- footerContainer ends -->
<div id="footerBottomContainer">
	<!-- #include virtual="/layout/footer-bottom.asp" -->
</div><!-- footerBottomContainer -->
</body>
</html>
